Brad Hively, Director at Oncology Institute, Inc. (TOI), bought 45,280 shares at $1.04 ($47K) on 2025-03-26, disclosed to the SEC on 2025-04-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| TOI | SELL | 2025-08-21 | $164K | — | Filing → |
| TOI | SELL | 2025-06-05 | $11.3M | — | Filing → |
| TOI | BUY | 2025-03-28 | $9K | — | Filing → |